CBIO
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, is focused on developing candidates for protease products in the fields of hemostasis and complement regulation. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $31 (+105.98%)
Market Cap
$432M
EPS 5Y CAGR
+34.96%
Free Cash Flow Yield
-17.69%
Beta (5Y)
0.74
Price Chart
Valuation
Market Cap$432M
P/S36.36
P/B2.33
Profitability
Total Revenue (TTM)$1.04M
Gross Profit (TTM)$12M
EBITDA-$93M
Operating Margin-2380%
EPS-$5.03
Financial Health
Free Cash Flow Yield-17.69%
Growth & Risk
EPS 5Y CAGR+34.96%
Revenue 5Y CAGR-14.08%
FCF 5Y CAGR+8.89%
Beta (5Y)0.74
Sharpe Ratio0.52